Growth momentum Orpyx is expanding its sensory insole platform with next generation solutions and has recently launched the Sensory Insole program to scale prevention of diabetic foot complications, signaling a broader target market and increased sales opportunities with healthcare providers and payers.

Health system ties Strong existing partnerships with VA Medical Centers and health systems across North America position Orpyx to pursue expanded contracts, remote monitoring services, and digital foot programs within large payer and provider networks.

Financial backing A recent $20 million growth funding round led by Perceptive Advisors enhances the company’s capacity to scale sales efforts, expand product offerings, and engage larger healthcare customers with confidence.

Market need Rising focus on preventing diabetic foot complications creates a large addressable market; Orpyx’s sensor-enabled insoles and real-time pressure alerts align with payer incentives and patient outcomes targets for reducing costly adverse events.

Global expansion Expansion activities, including office growth to Edmonton and broader North American reach, indicate a push toward regional sales development, channel partnerships, and increased probability of multi-market deployments.